Bridget Behringer

Bridget Behringer has over two decades of extensive experience in IT and business partnership roles within AstraZeneca, currently serving as the End-to-End R&D Lead Business Partner for R&D IT. Since joining AstraZeneca in 1990, Bridget has held various positions, including Oncology Digital Health Business Partner Lead and Senior IT Business Partner for Mergers and Acquisitions, where strategic IS/IT programs have been led to facilitate acquisitions and collaborations. Bridget's earlier roles include leading ISIT strategy in Neuroscience R&D and managing laboratory resources in Pharmaceutical Development, showcasing a strong focus on integrating technology with research and development. Bridget holds an MBA in Strategy from the Questrom School of Business at Boston University and a BA in Chemistry and Biology from the Massachusetts College of Liberal Arts.